Ulcerative colitis immune cell landscapes and differentially expressed gene signatures determine novel regulators and predict clinical response to biologic therapy
Abstract The heterogeneous pathobiology underlying Ulcerative Colitis (UC) is not fully understood. Using publicly available transcriptomes from adult UC patients, we identified the immune cell landscape, molecular pathways, and differentially expressed genes (DEGs) across patient cohorts and their...
Guardado en:
Autores principales: | Harrison M. Penrose, Rida Iftikhar, Morgan E. Collins, Eman Toraih, Emmanuelle Ruiz, Nathan Ungerleider, Hani Nakhoul, Erik F. Flemington, Emad Kandil, Shamita B. Shah, Suzana D. Savkovic |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e760a94f0fe148a6a82d2a1f02490469 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated ATGL in colon cancer cells and cancer stem cells promotes metabolic and tumorigenic reprogramming reinforced by obesity
por: Rida Iftikhar, et al.
Publicado: (2021) -
Serum miRNA signature diagnoses and discriminates murine colitis subtypes and predicts ulcerative colitis in humans
por: Emilie Viennois, et al.
Publicado: (2017) -
Infliximab in ulcerative colitis
por: Avi Levin, et al.
Publicado: (2008) -
Golimumab in unresponsive ulcerative colitis
por: Lippert E, et al.
Publicado: (2014) -
Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis
por: Bryan Linggi, et al.
Publicado: (2021)